References
- American Cancer Society. Cancer Facts & Figures 2016 [cited 2016]. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2016/cancer-facts-and-figures-2016.pdf
- Karim-Kos HE, de Vries E, Soerjomataram I, et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer (Oxford, England: 1990). 2008;44:1345–1389.
- Cress RD, Yin D, Clarke L, et al. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control. 2006;17:403–409.
- Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362:1605–1617.
- Konstantinidis IT, Warshaw AL, Allen JN, et al. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a “true” R0 resection? Annals of Surgery. 2013;257:731–736.
- Cameron JL, He J. Two thousand consecutive pancreaticoduodenectomies. J Am Coll Surg. 2015;220:530–536.
- Ansorge C, Lindstrom P, Strommer L, et al. Assessing surgical quality: comparison of general and procedure-specific morbidity estimation models for the risk adjustment of pancreaticoduodenectomy outcomes. World J Surg. 2014;38:2412–2421.
- McMillan MT, Christein JD, Callery MP, et al. Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy. Surgery. 2016;159:1013–1022.
- Enestvedt CK, Diggs BS, Cassera MA, et al. Complications nearly double the cost of care after pancreaticoduodenectomy. Am J Surg. 2012;204:332–338.
- Lee SR, Kim HO, Son BH, et al. Prognostic factors associated with long-term survival and recurrence in pancreatic adenocarcinoma. Hepatogastroenterology. 2013;60:358–362.
- Cordera F, Arciero CA, Li T, et al. Significance of common hepatic artery lymph node metastases during pancreaticoduodenectomy for pancreatic head adenocarcinoma. Ann Surg Oncol. 2007; 14:2330–2336.
- Akerberg D, Ansari D, Andersson R. Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas. World J Gastroenterol. 2016;22:6424–6433.
- Bilici A. Prognostic factors related with survival in patients with pancreatic adenocarcinoma. World J Gastroenterol. 2014;20: 10802–10812.
- De Rosa A, Cameron IC, Gomez D. Indications for staging laparoscopy in pancreatic cancer. HPB. 2016;18:13–20.
- Riediger H, Keck T, Wellner U, et al. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg. 2009;13:1337–1344.
- Valsangkar NP, Bush DM, Michaelson JS, et al. N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2013;17:257–266.
- Kayahara M, Nagakawa T, Kobayashi H, et al. Lymphatic flow in carcinoma of the head of the pancreas. Cancer. 1992;70: 2061–2066.
- Ishikawa O, Ohigashi H, Sasaki Y, et al. Practical grouping of positive lymph nodes in pancreatic head cancer treated by an extended pancreatectomy. Surgery. 1997;121:244–249.
- Connor S, Bosonnet L, Ghaneh P, et al. Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status. Br J Surg. 2004;91:1592–1599.
- Chen RF, Huang CM, Chen QY, et al. Why the proximal splenic artery approach is the ideal approach for laparoscopic suprapancreatic lymph node dissection in advanced gastric cancer? A large-scale vascular-anatomical-based study. Medicine. 2015;94:e832.
- van Rijssen LB, Narwade P, van Huijgevoort NC, et al. Prognostic value of lymph node metastases detected during surgical exploration for pancreatic or periampullary cancer: a systematic review and meta-analysis. HPB. 2016;18:559–566.
- Bogoevski D, Yekebas EF, Schurr P, et al. Mode of spread in the early phase of lymphatic metastasis in pancreatic ductal adenocarcinoma: prognostic significance of nodal microinvolvement. Ann Surg. 2004;240:993–1001.
- Maithel SK, Khalili K, Dixon E, et al. Impact of regional lymph node evaluation in staging patients with periampullary tumors. Ann Surg Oncol. 2007;14:202–210.
- Philips P, Dunki-Jacobs E, Agle SC, et al. The role of hepatic artery lymph node in pancreatic adenocarcinoma: prognostic factor or a selection criterion for surgery. HPB (Oxford). 2014; 16:1051–1055.
- Jones L, Russell C, Mosca F, et al. Standard kausch-whipple pancreatoduodenectomy. Dig Surg. 1999;16:297–304.
- Classification of regional lymph nodes in Japan. Int J Clin Oncol. 2003;8:248–275.
- LaFemina J, Chou JF, Gonen M, et al. Hepatic arterial nodal metastases in pancreatic cancer: is this the node of importance? J Gastrointest Surg. 2013;17:1092–1097.